文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The Antifungal Activity of Chitosan Nanoparticle-Incorporated Probiotics Against Oral Candidiasis.

作者信息

N S Shree Abiraami, Pillai Devika S, Shanmugam Rajeshkumar

机构信息

Oral Medicine and Radiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.

Nanobiomedicine, Centre for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.

出版信息

Cureus. 2024 Sep 24;16(9):e70093. doi: 10.7759/cureus.70093. eCollection 2024 Sep.


DOI:10.7759/cureus.70093
PMID:39449901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11501512/
Abstract

BACKGROUND: Candida species, especially , cause oral candidiasis, also known as oral thrush. It affects the elderly, newborns, patients under antibiotics, chemotherapeutic agents, and patients with weaker immune systems. Although successful, traditional antifungal medications are available, they may have negative effects and do not prevent recurrence. Conventional antifungal medications have a restricted range of effectiveness; hence, the need for a novel antifungal agent arises. Chitosan, a natural polymer made from chitin found in crustaceans, kills fungal cells by damaging membranes. Excellent biocompatibility and biodegradability make it a promising medical material. Probiotics, live bacteria, compete with pathogenic microbes for adhesion sites and nutrients, produce antimicrobials such as lactic acid, hydrogen peroxide, and bacteriocins, and modulate the host's immunological response. Adding probiotics to chitosan nanoparticles (CSNPs) boosts their antifungal activity against Candida species and increases their stability and transport to the infection site. METHODS: The antifungal activity was evaluated through in vitro experiments utilizing Candida strains that are significant to oral candidiasis. Different concentrations of CSNPs and formulations loaded with probiotics were examined to assess their effectiveness. The antifungal properties were assessed using microbiological assays, specifically agar diffusion and minimum inhibitory concentration (MIC). RESULTS: The study demonstrated a notable fungicidal impact of CSNPs combined with probiotics against oral candidiasis. Furthermore, the MIC values were lower for the probiotic-loaded CSNPs than for chitosan alone or probiotics alone. CONCLUSION: The combination of CSNPs and probiotics shows potential in effectively combating oral candidiasis by inhibiting fungal growth. This novel method offers a promising strategy for creating therapeutic treatments for oral candidiasis by utilizing the combined benefits of chitosan and probiotics to combat fungal infections effectively.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/bb4eaf22380b/cureus-0016-00000070093-i08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/a38340e046e1/cureus-0016-00000070093-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/f30936e1ec4c/cureus-0016-00000070093-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/fcf4b9a3d5da/cureus-0016-00000070093-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/eb3bca5ed832/cureus-0016-00000070093-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/79e6a9e72091/cureus-0016-00000070093-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/8a72c33d2eb5/cureus-0016-00000070093-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/8c28281f3523/cureus-0016-00000070093-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/bb4eaf22380b/cureus-0016-00000070093-i08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/a38340e046e1/cureus-0016-00000070093-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/f30936e1ec4c/cureus-0016-00000070093-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/fcf4b9a3d5da/cureus-0016-00000070093-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/eb3bca5ed832/cureus-0016-00000070093-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/79e6a9e72091/cureus-0016-00000070093-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/8a72c33d2eb5/cureus-0016-00000070093-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/8c28281f3523/cureus-0016-00000070093-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/11501512/bb4eaf22380b/cureus-0016-00000070093-i08.jpg

相似文献

[1]
The Antifungal Activity of Chitosan Nanoparticle-Incorporated Probiotics Against Oral Candidiasis.

Cureus. 2024-9-24

[2]
The anti-fungal effect of miconazole and miconazole-loaded chitosan nanoparticles gels in diabetic patients with Oral candidiasis-randomized control clinical trial and microbiological analysis.

BMC Oral Health. 2024-2-7

[3]
Novel Preclinical Study of Galloylquinic Acid Compounds from with Potent Antifungal Activity against Vaginal Candidiasis Induced in a Murine Model via Multitarget Modes of Action.

Microbiol Spectr. 2022-10-26

[4]
Exploring the Biofilm Inhibition Potential of a Novel Phytic Acid-Crosslinked Chitosan Nanoparticle: In Vitro and In Vivo Investigations.

AAPS PharmSciTech. 2024-5-9

[5]
Development of Probiotic Formulations for Oral Candidiasis Prevention: Gellan Gum as a Carrier To Deliver Lactobacillus paracasei 28.4.

Antimicrob Agents Chemother. 2020-5-21

[6]
Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.

J Clin Gastroenterol. 2012-10

[7]
Synthesis, characterization, and evaluation of the antifungal properties of tissue conditioner incorporated with essential oils-loaded chitosan nanoparticles.

PLoS One. 2022

[8]
The Anti-Biofilm Efficacy of Caffeic Acid Phenethyl Ester (CAPE) and a Murine Model of Oral Candidiasis.

Front Cell Infect Microbiol. 2021

[9]
Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.

Mycopathologia. 2018-3-1

[10]
Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis.

Int J Nanomedicine. 2016-6-10

引用本文的文献

[1]
Fungal Biofilm: An Overview of the Latest Nano-Strategies.

Antibiotics (Basel). 2025-7-17

[2]
Evaluation of the Antibacterial and Antifungal Efficacy of Chitosan Nanoparticles in Irreversible Hydrocolloid Impression Materials: A Cross-Sectional Study.

Cureus. 2025-2-3

本文引用的文献

[1]
Assessment of Antimicrobial Activity of Nanocomposites Based on Nano-Hydroxyapatite (HAP), Chitosan, and Vitamin K2.

Cureus. 2024-1-31

[2]
Synergistic Antimicrobial Activities of Chitosan Mixtures and Chitosan-Copper Combinations.

Int J Mol Sci. 2022-3-20

[3]
Chitosan: An Overview of Its Properties and Applications.

Polymers (Basel). 2021-9-24

[4]
Potential Antimicrobial Applications of Chitosan Nanoparticles (ChNP).

J Microbiol Biotechnol. 2019-7-28

[5]
Lactobacillus acidophilus ATCC 4356 inhibits biofilm formation by C. albicans and attenuates the experimental candidiasis in Galleria mellonella.

Virulence. 2015

[6]
Nanotechnology and dentistry.

Eur J Dent. 2013-1

[7]
Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial.

Crit Care Med. 2013-2

[8]
Antimicrobial properties of chitosan and mode of action: a state of the art review.

Int J Food Microbiol. 2010-10-15

[9]
Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.

Future Microbiol. 2009-9

[10]
Probiotics reduce the prevalence of oral candida in the elderly--a randomized controlled trial.

J Dent Res. 2007-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索